Nicholas Investment Partners, LP Magenta Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$5.57 - $11.65 $162,488 - $339,853
-29,172 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$11.32 - $15.7 $95,201 - $132,037
8,410 Added 40.51%
29,172 $350,000
Q2 2018

Aug 14, 2018
BUY
$13.5 - $14.52 $280,287 - $301,464
20,762 New
20,762 $280,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email